EP4431087A1 — A film coated tablet of sitagliptin or a pharmaceutically acceptable salt thereof
Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2024-09-18 · 2y expired
What this patent protects
The present invention relates to a film coated tablet comprising sitagliptin or a pharmaceutically acceptable salt thereof and at least two fillers and at least two lubricants wherein, lubricants are magnesium stearate and sodium stearyl fumarate. The present invention also relat…
USPTO Abstract
The present invention relates to a film coated tablet comprising sitagliptin or a pharmaceutically acceptable salt thereof and at least two fillers and at least two lubricants wherein, lubricants are magnesium stearate and sodium stearyl fumarate. The present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient method of preparing the formulation.
Drugs covered by this patent
- Steglatro (ERTUGLIFLOZIN) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.